SOCAP24: Going Deeper, Catalyzing Systems Change — Tracks and Curation Councils Released!

Psychedelic Medicine: The Good, The Bad, and the Ugly

Julia Mirer Nushama

An overview of the emerging industry of psychedelic medicine from a provider who has been on the front lines since 2018. I will provide a 101 of ketamine assisted therapy for mental health, and then dive into the potential of these medicines to heal addiction and chronic pain, all problems that our society is currently struggling with at unprecedented rates. I will discuss in detail the use of ketamine as a psychedelic medicine which is legal throughout the US. I will share professional insights into where this industry is going as well as what I have learned in the last 6 years. The good, the bad and the ugly will be covered to give the audience an accurate picture of the great potential and the possible pitfalls – allowing investors to make educated decisions as this industry continues to grow.

Track

Transforming Health Systems

Format

Brief and Bold (1 Speaker, keynote style)

Speakers

  • NameJulia Mirer
  • TitleDirector of Strategy & Impact
  • OrganizationNushama

Description

An overview of the emerging industry of psychedelic medicine from a provider who has been on the front lines since 2018. I will provide a 101 of ketamine assisted therapy for mental health, and then dive into the potential of these medicines to heal addiction and chronic pain, all problems that our society is currently struggling with at unprecedented rates. I will discuss in detail the use of ketamine as a psychedelic medicine which is legal throughout the US. I will share professional insights into where this industry is going as well as what I have learned in the last 6 years. The good, the bad and the ugly will be covered to give the audience an accurate picture of the great potential and the possible pitfalls – allowing investors to make educated decisions as this industry continues to grow.

Join the SOCAP Newsletter!